Cancer vaccines[edit]
Main article: Cancer vaccine
A cancer vaccine is a vaccine that treats existing cancer or prevents the development of cancer in certain high-risk individuals. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. There are currently no vaccines able to prevent cancer in general.
On April 14, 2009, Dendreon Corporation announced that their Phase III clinical trial of Provenge, a cancer vaccine designed to treat prostate cancer, had demonstrated an increase in survival. It received U.S. Food and Drug Administration (FDA) approval for use in the treatment of advanced prostate cancer patients on April 29, 2010.[17] The approval of Provenge has stimulated interest in this type of therapy.